134000-96-7Relevant articles and documents
Synthesis method of 2-chloro-5-fluoro-6-methylpyrimidine
-
Paragraph 0023; 0025; 0030; 0034, (2020/08/18)
The invention relates to a synthesis method of 2-chloro-5-fluoro-6-methylpyrimidine, which comprises the following steps: dissolving sodium methoxide in methanol, adding urea, stirring, dropwisely adding ethyl 2-fluoroacetoacetate, and carrying out a reflux reaction for 2-3 hours to obtain an intermediate A; mixing the intermediate A, phosphorus oxychloride and organic alkali according to a weightratio of 1: (5-10): (0.3-2) for reaction, cooling the mixture, removing redundant phosphorus oxychloride, adding water for quenching extraction, drying, and concentrating to obtain a product B; and adding ethanol, zinc powder and acetic acid into the product B, carrying out a heating reflux reaction for 10-16 hours, cooling, filtering, evaporating to remove the ethanol, extracting with an organicsolvent, evaporating to dryness to obtain a crude product, and carrying out vacuum distillation to obtain a pure product C, namely the 2-chloro-5-fluoro-6-methylpyrimidine. The method has the effectsthat the yield is increased, the time is shortened, the operation is simple, and the post-treatment process is simplified.
IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
-
Page/Page column 95, (2015/06/25)
Compounds having the following formula (I), or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.
TRPV3 Modulators
-
Page/Page column 56-57, (2012/10/08)
Disclosed herein are modulators of TRPV3 of formula (I) wherein X1, X2, R1, R2, Rx, and n are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.